1. An intensive approach to treatment for older patients with relapsed isolated NPM1 mutated AML. Issue 1 (2015) Authors: Dukka, Srivasavi; Bowen, David T. Journal: Leukemia research reports Issue: Volume 4:Issue 1(2015) Page Start: 18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Azacitidine‐eligibility in higher‐risk myelodysplastic syndromes and chronic myelomonocytic leukaemia: a registry‐based study. (7th January 2013) Authors: Durairaj, Senthilkumar; Keenan, Norene; Hyslop, Ann; Groves, Michael J.; Bowen, David T.; Tauro, Sudhir Journal: British journal of haematology Issue: Volume 161:Number 2(2013:Apr.) Page Start: 280 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cardiac iron overload assessed by T2* magnetic resonance imaging and cardiac function in regularly transfused myelodysplastic syndrome patients. (15th November 2013) Authors: Bowen, David T.; Hellström‐Lindberg, Eva; Steensma, David P. Journal: British journal of haematology Issue: Volume 164:Number 4(2014:Feb.) Page Start: 610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. High and low, but not intermediate, PRAME expression levels are poor prognostic markers in myelodysplastic syndrome at disease presentation. (18th April 2013) Authors: Liberante, Fabio G.; Pellagatti, Andrea; Boncheva, Viktoriya; Bowen, David T.; Mills, Ken I.; Boultwood, Jacqueline; Guinn, Barbara‐Ann Journal: British journal of haematology Issue: Volume 162:Number 2(2013:Jul.) Page Start: 282 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of socioeconomic status on disease phenotype, genomic landscape and outcomes in myelodysplastic syndromes. (20th April 2016) Authors: Mastaglio, Francesca; Bedair, Khaled; Papaemmanuil, Elli; Groves, Michael J.; Hyslop, Ann; Keenan, Norene; Hothersall, Eleanor J.; Campbell, Peter J.; Bowen, David T.; Tauro, Sudhir Journal: British journal of haematology Issue: Volume 174:Number 2(2016) Page Start: 227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Telomere length is an independent prognostic marker in MDS but not in de novo AML. (9th May 2017) Authors: Williams, Jenna; Heppel, Nicole H.; Britt‐Compton, Bethan; Grimstead, Julia W.; Jones, Rhiannon E.; Tauro, Sudhir; Bowen, David T.; Knapper, Steven; Groves, Michael; Hills, Robert K.; Pepper, Chris; Baird, Duncan M.; Fegan, Chris Journal: British journal of haematology Issue: Volume 178:Number 2(2017) Page Start: 240 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗